- Advanced search
- Immuno Portal
- Malaria Portal
lodoxamide is an approved drug (UK (1991), FDA (1993))
Compound class: Synthetic organic
Comment: Lodoxamide is a mast cell stabilizing anti-inflammatory drug. Clinically administered forms may contain lodoxamide trometamol/tromethamine.
Ligand Activity Visualisation Charts
These are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts.✖
|The precise mechanism of acton/primary molecular target of mast cell stabilizers is not fully resolved, so we have not associated any protein targets with this drug.
Lodoxamide inhibits the migration of THP-1 cells in vitro, in a GPR35-dependent manner .
|Selectivity at GPCRs|
|Key to terms and symbols||Click column headers to sort|